← SynDRA
SYN1265200
SynDRA canonical compound SYN1265200 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | LPAR1 |
|---|
| Mechanism of action | lysophosphatidic acid receptor antagonist |
|---|
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- AM095 free acid
- AM095 (free acid)
- AM095
- AM-095
- AM-095 free acid
- LNDDRUPAICPXIN-GOSISDBHSA-N
- MFCD22665734
- AM 095 (parent compound)
- GTPL6988
- orb1310008
- SCHEMBL2288084
- DZB69036
- EX-A1955
- BDBM50398127
- AKOS030525392
- CS-1129
- EBC-157212
- NCGC00378906-02
- AC-35875
- BS-14726
- HY-16040
- S6633
- T10293
- F865549
- BRD-K23952234-236-01-8
- Z3247511112
- EX-A1954
- AC-35293
- HY-16039
- CS-1118
- AM-095 Sodium
- orb1306786
- GLXC-10016
- AS-55886
- SCHEMBL29354386
- MFCD23380594
- AKOS030526424
- C27H23N2NaO5
- AM095, >=98% (HPLC)
- AM095 sodium
Look up SYN1265200 in the interactive SynDRA portal →